Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities.

Alber J, Alladi S, Bae HJ, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, Fossati S, Gottesman RF, Gustafson DR, Hachinski V, Hayden KM, Helman AM, Hughes TM, Isaacs JD, Jefferson AL, Johnson SC, Kapasi A, Kern S, Kwon JC, Kukolja J, Lee A, Lockhart SN, Murray A, Osborn KE, Power MC, Price BR, Rhodius-Meester HFM, Rondeau JA, Rosen AC, Rosene DL, Schneider JA, Scholtzova H, Shaaban CE, Silva NCBS, Snyder HM, Swardfager W, Troen AM, van Veluw SJ, Vemuri P, Wallin A, Wellington C, Wilcock DM, Xie SX, Hainsworth AH.

Alzheimers Dement (N Y). 2019 Apr 9;5:107-117. doi: 10.1016/j.trci.2019.02.001. eCollection 2019. Review.

2.

Randomized Trial of Marine n-3 Polyunsaturated Fatty Acids for the Prevention of Cerebral Small Vessel Disease and Inflammation in Aging (PUFA Trial): Rationale, Design and Baseline Results.

Bowman GL, Silbert LC, Dodge HH, Lahna D, Hagen K, Murchison CF, Howieson D, Kaye J, Quinn JF, Shinto L.

Nutrients. 2019 Mar 29;11(4). pii: E735. doi: 10.3390/nu11040735.

3.

Dietary patterns in early life pay dividends for midlife cognitive performance.

Bowman GL, Scarmeas N.

Neurology. 2019 Apr 2;92(14):645-646. doi: 10.1212/WNL.0000000000007229. Epub 2019 Mar 6. No abstract available.

PMID:
30842297
4.

Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood-Brain Barrier Permeability in Older Adults.

Dayon L, Cominetti O, Wojcik J, Galindo AN, Oikonomidi A, Henry H, Migliavacca E, Kussmann M, Bowman GL, Popp J.

J Proteome Res. 2019 Mar 1;18(3):1162-1174. doi: 10.1021/acs.jproteome.8b00809. Epub 2019 Feb 15.

PMID:
30702894
5.

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, Dreux S, Edland S, Esbensen A, Evered L, Ewers M, Fargo KN, Fortea J, Gonzalez H, Gustafson DR, Head E, Hendrix JA, Hofer SM, Johnson LA, Jutten R, Kilborn K, Lanctôt KL, Manly JJ, Martins RN, Mielke MM, Morris MC, Murray ME, Oh ES, Parra MA, Rissman RA, Roe CM, Santos OA, Scarmeas N, Schneider LS, Schupf N, Sikkes S, Snyder HM, Sohrabi HR, Stern Y, Strydom A, Tang Y, Terrera GM, Teunissen C, Melo van Lent D, Weinborn M, Wesselman L, Wilcock DM, Zetterberg H, O'Bryant SE; International Society to Advance Alzheimer's Research and Treatment, Alzheimer's Association.

Alzheimers Dement. 2019 Feb;15(2):292-312. doi: 10.1016/j.jalz.2018.09.009. Epub 2018 Dec 13.

6.

Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults.

Bowman GL, Dayon L, Kirkland R, Wojcik J, Peyratout G, Severin IC, Henry H, Oikonomidi A, Migliavacca E, Bacher M, Popp J.

Alzheimers Dement. 2018 Dec;14(12):1640-1650. doi: 10.1016/j.jalz.2018.06.2857. Epub 2018 Aug 14. Erratum in: Alzheimers Dement. 2019 Feb;15(2):319.

PMID:
30120040
7.

Alzheimer disease pathology and the cerebrospinal fluid proteome.

Dayon L, Núñez Galindo A, Wojcik J, Cominetti O, Corthésy J, Oikonomidi A, Henry H, Kussmann M, Migliavacca E, Severin I, Bowman GL, Popp J.

Alzheimers Res Ther. 2018 Jul 18;10(1):66. doi: 10.1186/s13195-018-0397-4.

8.

Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.

Dayon L, Wojcik J, Núñez Galindo A, Corthésy J, Cominetti O, Oikonomidi A, Henry H, Migliavacca E, Bowman GL, Popp J.

J Alzheimers Dis. 2017;60(4):1641-1652. doi: 10.3233/JAD-170426.

9.

Biomarkers for early detection of Parkinson disease: A scent of consistency with olfactory dysfunction.

Bowman GL.

Neurology. 2017 Oct 3;89(14):1432-1434. doi: 10.1212/WNL.0000000000004383. Epub 2017 Sep 6. No abstract available.

PMID:
28878052
10.

One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond.

Dayon L, Guiraud SP, Corthésy J, Da Silva L, Migliavacca E, Tautvydaitė D, Oikonomidi A, Moullet B, Henry H, Métairon S, Marquis J, Descombes P, Collino S, Martin FJ, Montoliu I, Kussmann M, Wojcik J, Bowman GL, Popp J.

Alzheimers Res Ther. 2017 Jun 17;9(1):43. doi: 10.1186/s13195-017-0270-x.

11.

Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.

Popp J, Oikonomidi A, Tautvydaitė D, Dayon L, Bacher M, Migliavacca E, Henry H, Kirkland R, Severin I, Wojcik J, Bowman GL.

Brain Behav Immun. 2017 May;62:203-211. doi: 10.1016/j.bbi.2017.01.020. Epub 2017 Feb 1.

12.

Nutrition for the ageing brain: Towards evidence for an optimal diet.

Vauzour D, Camprubi-Robles M, Miquel-Kergoat S, Andres-Lacueva C, Bánáti D, Barberger-Gateau P, Bowman GL, Caberlotto L, Clarke R, Hogervorst E, Kiliaan AJ, Lucca U, Manach C, Minihane AM, Mitchell ES, Perneczky R, Perry H, Roussel AM, Schuermans J, Sijben J, Spencer JP, Thuret S, van de Rest O, Vandewoude M, Wesnes K, Williams RJ, Williams RS, Ramirez M.

Ageing Res Rev. 2017 May;35:222-240. doi: 10.1016/j.arr.2016.09.010. Epub 2016 Oct 3. Review.

13.

Ascorbic acid and the brain: rationale for the use against cognitive decline.

Harrison FE, Bowman GL, Polidori MC.

Nutrients. 2014 Apr 24;6(4):1752-81. doi: 10.3390/nu6041752. Review.

14.

Plasma omega-3 PUFA and white matter mediated executive decline in older adults.

Bowman GL, Dodge HH, Mattek N, Barbey AK, Silbert LC, Shinto L, Howieson DB, Kaye JA, Quinn JF.

Front Aging Neurosci. 2013 Dec 16;5:92. doi: 10.3389/fnagi.2013.00092. eCollection 2013.

15.

Memory, mood, and vitamin D in persons with Parkinson's disease.

Peterson AL, Murchison C, Zabetian C, Leverenz JB, Watson GS, Montine T, Carney N, Bowman GL, Edwards K, Quinn JF.

J Parkinsons Dis. 2013;3(4):547-55. doi: 10.3233/JPD-130206.

16.

Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease.

Bowman GL, Kaye JA, Quinn JF.

Curr Gerontol Geriatr Res. 2012;2012:184042. doi: 10.1155/2012/184042. Epub 2012 May 13.

17.

Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction.

Bowman GL.

Biofactors. 2012 Mar-Apr;38(2):114-22. doi: 10.1002/biof.1002. Epub 2012 Mar 15. Review.

18.

Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment.

Bowman GL, Shannon J, Ho E, Traber MG, Frei B, Oken BS, Kaye JA, Quinn JF.

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):49-57. doi: 10.1097/WAD.0b013e3181f333d6.

19.

Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study.

Dodge HH, Katsumata Y, Todoriki H, Yasura S, Willcox DC, Bowman GL, Willcox B, Leonard S, Clemons A, Oken BS, Kaye JA, Traber MG.

J Gerontol A Biol Sci Med Sci. 2010 Oct;65(10):1060-7. doi: 10.1093/gerona/glq124. Epub 2010 Jul 19.

20.

Uric acid as a CNS antioxidant.

Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF.

J Alzheimers Dis. 2010;19(4):1331-6. doi: 10.3233/JAD-2010-1330.

Supplemental Content

Loading ...
Support Center